A high-throughput workflow integrates DNA methylation and RNA sequencing in single cells, enabling more complete insights ...
Leveraging an AI-powered omnimodal foundation model to accelerate drug discovery, optimize patient stratification, and de-risk clinical developmentWALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, a ...
BostonGene, developer of the leading AI foundation model for tumor and immune biology, announced results from the FEASY study ...
Qlucore, listed on Nasdaq First North, announces the launch of a new Qlucore Insights test (Research Use Only) specifically developed for Acute Myeloid Leukemia (AML). The software-based test delivers ...
Pulmonary fibrosis is a progressive interstitial lung disease characterized by excessive extracellular matrix deposition, ...
Cancer metabolism has re-emerged as a central hallmark of tumor initiation, progression, and therapeutic resistance. Advances in high-throughput ...
The study traced a major germination-related locus on chromosome 8 and linked stronger GmJAZ8 expression with faster seed sprouting. By clarifying how ...
For most patients diagnosed with kidney cancer, the standard playbook is clear. Immunotherapy and targeted therapies directed ...
Radiopharmaceuticals are rapidly becoming one of the most dynamic areas of oncology drug development. By combining molecular targeting with controlled radiation delivery, these therapies introduce a ...
For farms hesitant to increase fiber inclusion, the 14% improvement in energy prediction accuracy provides a more reliable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results